Ginkgo Bioworks grants RSUs to founder Reshma Shetty

Shetty Reshma P. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shetty Reshma P. reported acquisition or exercise transactions in this Form 4 filing.

Ginkgo Bioworks Holdings, Inc. reported that President and Founder Reshma P. Shetty received four equity awards on July 28, 2026 in the form of restricted stock units convertible into Class A Common Stock. Directly and through her spouse, she was granted 39038, 127423, 35736 and 117135 RSUs. For awards with footnote F2, 75% vests on October 16, 2026 and 25% on January 21, 2027, while awards with footnote F3 vest in equal quarterly installments over 12 quarters starting October 16, 2026.

Insider Trade Summary

Grant/Award: 319,332 shares

Grant/Award 4 txns

Insider Shetty Reshma P.

Role See remarks

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2	39,038	--	--
Grant/Award	Restricted Stock Units F1, F3	127,423	--	--
Grant/Award	Restricted Stock Units F1, F2	35,736	--	--
Grant/Award	Restricted Stock Units F1, F3	117,135	--	--

Holdings After Transaction: Restricted Stock Units — 166,461 contracts (Direct); Restricted Stock Units — 152,871 contracts (Indirect, By Spouse)

Footnotes (3)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. F2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
3. F3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.

Key Figures

RSU grant size (direct): 39038 RSUs RSU grant size (direct): 127423 RSUs RSU grant size (indirect by spouse): 35736 RSUs +3 more

6 metrics

RSU grant size (direct) 39038 RSUs Restricted stock units granted directly to Reshma Shetty on July 28, 2026

RSU grant size (direct) 127423 RSUs Additional restricted stock units granted directly on July 28, 2026

RSU grant size (indirect by spouse) 35736 RSUs Restricted stock units reported as held indirectly "By Spouse"

RSU grant size (indirect by spouse) 117135 RSUs Additional RSUs reported as held indirectly "By Spouse"

Vesting tranches 75% and 25% For F2 RSUs, 75% vests on Oct 16, 2026 and 25% on Jan 21, 2027

Vesting period for F3 awards 12 quarters F3 RSUs vest in equal quarterly installments over 12 quarters starting Oct 16, 2026

Key Terms

Restricted Stock Units, Class A Common Stock, Compensation Committee, quarterly installments, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"right to receive one share of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Compensation Committee financial

"The RSUs were approved by the Compensation Committee of the Board of Directors"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

quarterly installments financial

"shall vest in equal quarterly installments over the next 12 quarters"

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Ginkgo Bioworks (DNA) report for Reshma Shetty?

Ginkgo Bioworks reported that Reshma P. Shetty, President, Founder and director, received four grants of restricted stock units on July 28, 2026, which convert into Class A Common Stock as they vest under specified schedules.

How many restricted stock units did Reshma Shetty receive at Ginkgo Bioworks (DNA)?

Reshma Shetty received four RSU grants representing 39038, 127423, 35736 and 117135 units. Each restricted stock unit represents a contingent right to receive one share of Ginkgo Bioworks’ Class A Common Stock upon vesting.

What are the vesting terms of the new RSUs reported by Ginkgo Bioworks (DNA)?

Two RSU grants vest 75% on October 16, 2026 and 25% on January 21, 2027. The other two grants vest in equal quarterly installments over 12 quarters, beginning October 16, 2026, subject to the continued vesting conditions.

Are any of the Ginkgo Bioworks (DNA) RSU awards held indirectly through a spouse?

Yes. Two of the RSU grants, for 35736 and 117135 units, are reported as held indirectly "By Spouse". The other two grants, for 39038 and 127423 units, are reported as held directly by Reshma Shetty.

Does this Ginkgo Bioworks (DNA) Form 4 disclose any stock sales by Reshma Shetty?

No. The Form 4 reports only acquisitions of restricted stock units (transaction code A) and shows no sales or dispositions of Ginkgo Bioworks Class A Common Stock or derivatives in the reported period.

Who approved the RSU grants disclosed by Ginkgo Bioworks (DNA)?

The RSU grants were approved by the Compensation Committee of the Board of Directors on July 28, 2026. The committee also determined the vesting schedules, including the 75%/25% tranches and the 12 quarterly installments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:27 PM Accepted by SEC EDGAR 07/30/2026 - 04:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shetty Reshma P.

(Last) (First) (Middle)

C/O GINKGO BIOWORKS HOLDINGS

27 DRYDOCK AVENUE

(Street)

BOSTON MASSACHUSETTS 02210

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ginkgo Bioworks Holdings, Inc. [ DNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	See remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	07/28/2026		A		39,038		(2)	(2)	Class A Common Stock	39,038	(1)	39,038	D
Restricted Stock Units	(1)	07/28/2026		A		127,423		(3)	(3)	Class A Common Stock	127,423	(1)	127,423	D
Restricted Stock Units	(1)	07/28/2026		A		35,736		(2)	(2)	Class A Common Stock	35,736	(1)	35,736	I	By Spouse
Restricted Stock Units	(1)	07/28/2026		A		117,135		(3)	(3)	Class A Common Stock	117,135	(1)	117,135	I	By Spouse

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.

3. The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.

Remarks:

President & Founder

	/s/ Karen Tepichin, Attorney-in-Fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)